Clinical Expertise Areas

Cardiovascular disease

We have a long history of making an impact in cardiovascular disease. Nearly 70 years after we introduced our first cardiovascular therapy, we continue to advance research for cardiovascular diseases.

Our approch on cardiovascular disease research and treatments

Cardiovascular disease continues to be one of the most serious global health challenges. We strive for scientific excellence and are committed to advancing research for patients impacted by cardiovascular diseases. Our focus on cardiovascular diseases includes heart failure and atherosclerotic cardiovascular disease.

Facts and Figure

The impact of cardiovascular disease worldwide

Cardiovascular disease

Hypercholesterolemia

~20.5M

~24.1%

Annual deaths worldwide from cardiovascular disease in 2022:. In the U.S. in 2023: ~941,000 deaths from cardiovascular disease

Percentage of adults worldwide living with hypercholesterolemia (high cholesterol); ~86M adults in the U.S. are affected

Cardiovascular

We continue to build on our history of innovative therapies in heart disease to help increase our understanding and help patients around the world.

Hypercholesterolemia

Hypercholesterolemia, a type of hyperlipidemia, is a disorder in which there are elevated LDL cholesterol (LDL-C) levels in the blood. About 24% of adults worldwide have hypercholesterolemia, also known as high cholesterol, which is a major causal risk factor for atherosclerotic cardiovascular disease (ASCVD), a leading cause of death. People who have elevated LDL cholesterol levels often have no symptoms, so they may not know they have high LDL cholesterol.

Clinical trial Experience

Actively contribute to global preclinical cardiovascular research focused on identifying novel therapeutic targets and understanding disease mechanisms. Support discovery activities, early-stage feasibility assessments, data review, and cross-functional collaboration to advance potential treatments for cardiovascular disease.

Assist in designing and supporting preclinical study plans, coordinating research activities, and ensuring high-quality data generation to inform next-phase decisions. Work closely with scientific and clinical teams to evaluate early findings and prepare candidates for future clinical development aimed at improving cardiovascular patient outcomes.

Research With Purpose

Connected approach to your cardiovascular trials Through our Connected Intelligence approach to cardiovascular development, Geventis can help you rethink old challenges and surround your trials with a proven suite of capabilities to help you reach milestones faster, deliver programs within budget, and bring game-changing therapies to patients sooner.

We welcome your inquiries and will respond promptly.